Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karolina Adam is active.

Publication


Featured researches published by Karolina Adam.


American Journal of Obstetrics and Gynecology | 1994

Nimodipine in the management of preeclampsia: Maternal and fetal effects

Michael A. Belfort; George R. Saade; Kenneth J. Moise; Arcadia Cruz; Karolina Adam; Wayne B. Kramer; Brian Kirshon

OBJECTIVE Our purpose was to determine the effects of orally administered nimodipine on selected maternal and fetal parameters in patients with preeclampsia. STUDY DESIGN Ten consecutive patients were given 30 mg of nimodipine orally every 4 hours from admission until 24 hours after delivery. Maternal and fetal cerebral blood velocity, umbilical artery blood velocity, fetal heart rate variability, maternal blood pressure and heart rate, and transplacental passage of the drug were studied. All 10 patients were delivered within 24 hours of the first dose of nimodipine. RESULTS There was an acute and significant reduction in the pulsatility index in the smaller diameter maternal cerebral arteries (ophthalmic and central retinal) and in the fetal middle cerebral artery. The umbilical artery systolic/diastolic ratio was also significantly reduced. Maternal blood pressure was controlled without the need for other antihypertensive medication, and although there was an increase in heart rate after administration of the drug, it was well tolerated. Nimodipine reached significant maternal and fetal levels within 2 hours. CONCLUSIONS Nimodipine is rapidly absorbed after oral administration and has significant maternal and fetal cerebral vasodilator activity. It is an effective, easily administered antihypertensive agent when used in patients with preeclampsia.


American Journal of Obstetrics and Gynecology | 1995

Massive fetomaternal hemorrhage treated with serial combined intravascular and intraperitoneal fetal transfusions

Lynn D. Montgomery; Michael A. Belfort; Karolina Adam

One of the many causes of fetal hydrops is fetomaternal hemorrhage. This report presents a pregnancy with fetomaternal hemorrhage that was treated with serial combined intravascular and intraperitoneal fetal transfusions, resulting in a good outcome. A 26-year-old woman seen for ultrasonographic evaluation was found to have a fetus with hydrops fetalis. Fetal blood sampling demonstrated severe fetal anemia (hematocrit 16.4%). The initial Kleihauer-Betke test result on maternal blood was 6% fetal cells. The fetus was transfused five times over a 24-day period by means of a combined intravascular and intraperitoneal route. The fetus also received one platelet transfusion for thrombocytopenia. The pregnancy resulted in a good fetal outcome without the need for postpartum transfusion. This case represents successful treatment of fetal anemia and nonimmune hydrops with a serial combined intravascular and intraperitoneal transfusion technique.


American Journal of Obstetrics and Gynecology | 1988

The effects of magnesium sulfate therapy on Apgar scores

Kathleen M. Pruett; Brian Kirshon; David B. Cotton; Karolina Adam; Kevin J. Doody

When intravenous magnesium sulfate is infused in women with pregnancy-induced hypertension, the hypermagnesemia does not result in lower Apgar scores. The mean maternal serum and cord magnesium levels at delivery were 5.3 +/- 0.72 and 5.3 +/- 1.1 mEq/dl, respectively. The most common negative Apgar score was assigned for color, not for muscle tone.


Journal of Pediatric Surgery | 2011

Fetal lung interstitial tumor: a cause of late gestation fetal hydrops

David A. Lazar; Darrell L. Cass; Megan K. Dishop; Karolina Adam; Olutoyin A. Olutoye; Nancy A. Ayres; Christopher I. Cassady; Oluyinka O. Olutoye

Most fetal lung masses present by mid gestation, grow during the canalicular phase of lung development (18-26 weeks of gestation), and plateau in growth or shrink after 26 weeks of gestation. We describe the unique case of a fetal lung mass presenting at 37 weeks of gestation with hydrops and fetal heart failure. The late growth of this lesion and resultant hydrops prompted resection as part of the ex utero intrapartum treatment. Histopathology revealed a rare, recently described fetal lung interstitial tumor. This case demonstrates that a subset of fetal lung masses may continue to grow later in gestation and emphasizes the need for late gestation imaging and close follow-up in this patient cohort.


Journal of The American Society of Echocardiography | 1999

Doppler Echocardiography as a Predictor of Pregnancy Outcome in the Presence of Aortic Stenosis: A Case Report

Susan Wilansky; Ba Phan; Karolina Adam

Aortic stenosis in pregnancy can be a life-threatening condition, but fortunately it is rare. In the modern era, careful obstetric and cardiologic monitoring, particularly through echocardiography, have improved fetal and maternal outcomes. However, a test that could predict outcome has not been available for patients with aortic stenosis who seek prepregnancy counseling. We report a case in which exercise Doppler echocardiography was used to predict cardiac function and maximal gradients in a woman with a bicuspid aortic valve who wished to become pregnant.


Fetal Diagnosis and Therapy | 1993

Combined Effect of Terbutaline and Betamethasone on Glucose Homeostasis in Preterm Labor

Karolina Adam; Ching-Nan Ou; David B. Cotton

The short- and long-term effects of simultaneous administration of terbutaline and betamethasone were investigated in 8 gravidas treated for preterm labor. Their plasma concentrations of glucose, insulin, glucagon, C-peptide, lactate and potassium were compared to a control group receiving intravenous magnesium sulfate and betamethasone. The patients on terbutaline therapy had a marked hyperglycemia at 11 h which remained elevated for 48 h. There was a simultaneous rise in plasma insulin and C-peptide, and a fall in plasma glucagon. Lactate levels were markedly elevated. Only 1 of the 8 patients had an abnormal glucose tolerance test at 1 week of therapy. The metabolic changes of control patients were minimal in comparison and there was no lacticacidemia. This suggests that glucocorticoids potentiate the hyperglycemic response of terbutaline.


Case Reports | 2016

Uterine incarceration in a primigravid retroverted bicornuate uterus

Haleema Sadath; Robert J. Carpenter; Karolina Adam

Uterine incarceration is a rare complication that usually occurs after the first trimester of pregnancy. It leads to increased maternal and/or fetal morbidity and mortality. Risk factors include retroversion of uterus and other pelvic abnormalities. Clinical presentation includes severe abdominal and pelvic pain symptoms. Patients can present with concurrent urinary symptoms due to increasing distortion of adjacent structures from the enlarging uterus. A high clinical suspicion of uterine incarceration is confirmed with ultrasound. More advanced imaging such as MRI can be used as an adjunct to ultrasound imaging. Progression from expectant management to intervention is recommended as soon as possible to prevent complications such as uterine rupture and fetal demise. In subsequent pregnancies, close monitoring with serial ultrasounds is warranted to monitor for recurrence of incarceration which has been reported in a few rare cases.


American Journal of Obstetrics and Gynecology | 2003

Antibiotic therapy in preterm premature rupture of membranes: Are seven days necessary? A preliminary, randomized clinical trial

David F. Lewis; C. David Adair; Alfred G. Robichaux; Ronald Jaekle; Jodi A. Moore; Arthur T. Evans; M. Todd Fontenot; Brian M. Mercer; Karolina Adam; Mara J. Dinsmoor; Robert Mittendorf


Obstetrics & Gynecology | 1989

Intravenous pancuronium bromide for fetal neuromuscular blockade during intrauterine transfusion for red-cell alloimmunization

Kenneth J. Moise; Russell L. Deter; Brian Kirshon; Karolina Adam; David E. Patton; Robert J. Carpenter


Obstetrics & Gynecology | 1994

Inaccurate noninvasive mitral valve area calculation during pregnancy.

Roxann Rokey; Helen W. Hsu; Kenneth J. Moise; Karolina Adam; Nathan Wasserstrum

Collaboration


Dive into the Karolina Adam's collaboration.

Top Co-Authors

Avatar

Brian Kirshon

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kenneth J. Moise

Memorial Hermann Healthcare System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arcadia Cruz

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

David B. Cotton

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

George R. Saade

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wayne B. Kramer

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge